Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard

Stock Information for Covalon Technologies Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Covalon Technologies Ltd.

Covalon Reports Fifth Consecutive Quarter of Positive Earnings
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results
Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities
Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.